|
AFAP1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.01560000304235E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.51840009851878E-10 |
| Normal-vs-Stage2 |
3.340100E-02 |
| Normal-vs-Stage3 |
3.421600E-03 |
| Normal-vs-Stage4 |
9.495800E-03 |
| Stage1-vs-Stage2 |
3.991600E-02 |
| Stage1-vs-Stage3 |
4.616700E-03 |
| Stage1-vs-Stage4 |
9.266400E-02 |
| Stage2-vs-Stage3 |
9.062000E-01 |
| Stage2-vs-Stage4 |
6.344200E-01 |
| Stage3-vs-Stage4 |
6.609600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.11470000399672E-08 |
| Normal-vs-AfricanAmerican |
2.464300E-02 |
| Normal-vs-Asian |
3.422400E-01 |
| Caucasian-vs-AfricanAmerican |
6.705200E-01 |
| Caucasian-vs-Asian |
8.562800E-01 |
| AfricanAmerican-vs-Asian |
9.865200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.88239999985041E-07 |
| Normal-vs-Female |
5.59910000030861E-07 |
| Male-vs-Female |
5.322000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.897400E-03 |
| Normal-vs-Age(41-60Yrs) |
5.85510000039591E-07 |
| Normal-vs-Age(61-80Yrs) |
1.30119999997014E-06 |
| Normal-vs-Age(81-100Yrs) |
4.362200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.072000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.899170E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.536300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.594000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.324380E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.596220E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.860000E-03 |
| Normal-vs-Grade 2 |
3.70270003546835E-09 |
| Normal-vs-Grade 3 |
6.816600E-04 |
| Normal-vs-Grade 4 |
3.403900E-03 |
| Grade 1-vs-Grade 2 |
1.872100E-02 |
| Grade 1-vs-Grade 3 |
1.258250E-02 |
| Grade 1-vs-Grade 4 |
1.908150E-02 |
| Grade 2-vs-Grade 3 |
3.296500E-03 |
| Grade 2-vs-Grade 4 |
3.527800E-01 |
| Grade 3-vs-Grade 4 |
3.528800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.62299995665194E-09 |
| Normal-vs-ccB subtype |
3.52879999999667E-05 |
| ccA subtype-vs-ccB subtype |
3.402000E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.82540000000153E-05 |
| Normal-vs-N1 |
8.525800E-02 |
| N0-vs-N1 |
3.344000E-01 |
|
|
